As biotechnology enters a new phase of disciplined investment and precision-driven innovation, leaders who can bridge sc...
As biologics become increasingly sophisticated and development timelines continue to shrink, the role of Contrac...
At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
We’re seeing China move much more aggressively to bring innovative therapies beyond its borders. From your vantage...
The latest budget introduces several measures that may influence the pharmaceutical, biotechnology, and wider life scien...
As space missions become longer and human spaceflight programmes expand, countries across Asia Pacific are increasing ef...
The rise of advanced therapies is fundamentally reshaping the contract manufacturing landscape, pushing CDMOs to evolve ...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
How has the medical education system evolved within Australia? And what are the current challenges? In Australia, ther...
As Asia’s biologics ecosystem continues to scale rapidly across monoclonal antibodies, biosimilars, and ad...
South Korea’s CGT ecosystem is diverse and expanding, with a good mix of both early-stage startups, large pharma c...
New approach methodologies (NAMs) are scientific approaches that replace, reduce, or refine the use of animals in resear...
On February 12, the Singapore government presented its 2026 National Budget, positioning it as a first step toward secur...
China’s 2026 budget marks the beginning of the 15th Five-Year Plan, placing technology and innovation at the centr...
AI is now firmly embedded across the pharmaceutical value chain, from drug discovery to clinical research and manufactur...
Digital health is now a key part of modern medicine. Since app stores emerged in 2008, more than one million consumer di...
As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...
